Insider · CIK 0001261506

Dawes Karen A

CIK 0001261506 Name as filed on the most recent filing

Filed as Dawes Karen A (36)

105 transaction lines · from 36 filings · filed 2006-09-05 to 2025-12-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

105 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-07-20 S, Open-market sale Repligen CorpRGEN 124,710, disposed Open Form 4 filing 0000899243-21-029561
2021-07-20 S, Open-market sale Repligen CorpRGEN 57,603, disposed Open Form 4 filing 0000899243-21-029561
2021-07-13 S, Open-market sale Repligen CorpRGEN 4 lines 307,395, disposed Open Form 4 filing 0000899243-21-029533
2021-07-13 S, Open-market sale Repligen CorpRGEN 307,390, acquired Open Form 4 filing 0000899243-21-028505
2021-05-11 S, Open-market sale Repligen CorpRGEN 50,402, disposed Open Form 4 filing 0000899243-21-019419
2021-05-04 P, Open-market purchase Vaccitech plcVACC 28,900, acquired Open Form 4 filing 0001104659-21-062434
2020-06-18 S, Open-market sale Repligen CorpRGEN 4 lines 2,154,851, disposed Open Form 4 filing 0000899243-20-017371
2020-05-20 S, Open-market sale Repligen CorpRGEN 4 lines 72,093, disposed Open Form 4 filing 0000899243-20-013933
2020-05-18 S, Open-market sale Repligen CorpRGEN 7 lines 220,448, disposed Open Form 4 filing 0000899243-20-013931
2020-05-18 S, Open-market sale Repligen CorpRGEN 7 lines 220,448, disposed Open Form 4 filing 0000899243-20-013636
2020-05-08 S, Open-market sale Assertio Therapeutics, IncASRT 12,531, disposed Open Form 4 filing 0001005201-20-000037
2020-04-20 S, Open-market sale Repligen CorpRGEN 2 lines 1,275,717, disposed Open Form 4 filing 0000899243-20-013929
2020-04-20 S, Open-market sale Repligen CorpRGEN 2 lines 1,275,717, disposed Open Form 4 filing 0000899243-20-011171
2020-02-21 S, Open-market sale Repligen CorpRGEN 4 lines 394,793, disposed Open Form 4 filing 0000899243-20-005633
2019-06-17 S, Open-market sale Repligen CorpRGEN 100,168, disposed Open Form 4 filing 0000899243-19-017483
2019-06-13 S, Open-market sale Assertio Therapeutics, IncASRT 39,794, disposed Open Form 4 filing 0001005201-19-000082
2018-12-03 S, Open-market sale Assertio Therapeutics, IncASRT 40,725, disposed Open Form 4 filing 0001005201-18-000025
2018-05-11 S, Open-market sale Repligen CorpRGEN 835,936, disposed Open Form 4 filing 0001140361-18-023543
2017-03-21 S, Open-market sale Repligen CorpRGEN 86,017, disposed Open Form 4 filing 0001140361-17-012956
2013-06-21 P, Open-market purchase Repligen CorpRGEN 7,700, acquired Open Form 4 filing 0001140361-13-025991
2013-03-06 P, Open-market purchase Depomed IncDEPO 11,920, acquired Open Form 4 filing 0001179110-13-004438
2011-08-12 P, Open-market purchase Repligen CorpRGEN 34,946, acquired Open Form 4 filing 0001140361-11-041698
2011-06-14 P, Open-market purchase Repligen CorpRGEN 12,888, acquired Open Form 4 filing 0001140361-11-032955
2011-06-14 P, Open-market purchase Repligen CorpRGEN 2,490, acquired Open Form 4 filing 0001140361-11-032955

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 11
  • Open-market sale 94
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. DAWES KAREN A, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001261506

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.